Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by KingWhatsion Nov 08, 2010 10:49am

410 Views

Post# 17673291

RE: RE: Today is the day

The market makers are very clever. They know guys like us are hanging on every word. We don't have a lot of money to lose and most of all, we are greedy. So...

It's a simple thing to drop the price dramatically to give the impression that the meeting didn't go well and frighten us into selling out fast before our entire stash is gone. A trap.

Cooler heads will look at the volume and plainly see it is not a sell off.

Patience

Bullboard Posts

Dynamic Funds Launches new ETF series on the TSX